Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0%
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for HELIX BIOMEDIX INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.
Market information source · Oct 19, 2026
SEC company identity · Oct 19, 2026
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| BEATTY R STEPHEN | OtherD (derivative) | $1.3K | SEC | ||
| BEATTY R STEPHEN |
| OtherD (derivative) |
| n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| SEC |
| BEATTY R STEPHEN | Buy | $15K | conv 82First in 12mo | SEC |
| BEATTY R STEPHEN | OtherD (derivative) | $12.5K | SEC |